Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
BioPharma Drive: Drug Pricing
JANUARY 30, 2025
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
Let's personalize your content